Pathos
Ryan Fukushima started their work experience as a Senior Associate at Hyde Park Venture Partners in 2013. Ryan then worked as a VC & EIR at Lightbank from February 2014 to 2016, where they led investments in Enterprise software and marketplace companies. In 2015, Ryan joined Tempus, Inc. as the Chief Operating Officer, contributing to the advancement of precision medicine through the practical application of artificial intelligence in healthcare. Since July 2021, Ryan has been the CEO and Co-founder of Pathos.
Ryan Fukushima has a Bachelor of Science degree in Engineering from California Polytechnic State University-San Luis Obispo. Ryan also holds an MBA in Business from the University of Michigan. No specific start or end years were provided for either of these educational experiences.
This person is not in any offices
Pathos
Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthroughtherapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.